Skip to content
Doctor licensed in Poland · PWZ 3211301 Prescription on the EU model Every day, 5am to 11pm (Irish time)

Saxenda (liraglutide): the daily injection for weight management

Saxenda contains liraglutide and is injected under the skin once a day. It is licensed for weight management, together with a reduced-calorie diet and more physical activity. This page explains how it works, how the dose is built up over the first weeks, when treatment is stopped, which side effects are reported most often, who needs to be careful and how it differs from the weekly injections.

What Saxenda is used for

According to section 4.1 of the summary of product characteristics (SmPC), Saxenda is used for weight management in adults with obesity, or with overweight and at least one weight-related condition such as prediabetes or type 2 diabetes, high blood pressure, abnormal blood fats (dyslipidaemia) or obstructive sleep apnoea. It is always combined with a reduced-calorie diet and increased physical activity.

The SmPC also covers adolescents aged 12 and over with obesity and a body weight above 60 kg, and children aged 6 to under 12 with obesity and a body weight of at least 45 kg. For children, it says treatment should be started by a physician experienced in managing obesity in children. An overview of all weight management injections is on our page on weight loss injections.

The 12-week review

The Saxenda SmPC builds a stopping rule into the licence. For adults, treatment should be stopped after 12 weeks on 3.0 mg a day if you have not lost at least 5% of your initial body weight. For adolescents and children, the SmPC sets a different measure: treatment is stopped and re-evaluated if they have not achieved the reduction set out in section 4.1 after 12 weeks on 3.0 mg a day or the highest dose they tolerate.

In practice that gives treatment a clear checkpoint. Keep a record of your starting weight and of the date you reached 3.0 mg, because a doctor assessing a request to continue may ask for both.

How liraglutide works

Liraglutide is a GLP-1 analogue with 97% amino acid sequence homology to human GLP-1, the hormone it imitates, and it binds to and activates the GLP-1 receptor. The SmPC explains that GLP-1 is a physiological regulator of appetite and food intake. Liraglutide increases feelings of fullness and satiety and lowers feelings of hunger, which leads to reduced food intake; compared with placebo, it does not increase the energy the body uses. The weight lost is mainly fat, with a relatively greater reduction in visceral fat than in fat under the skin.

Liraglutide causes a small delay in the emptying of the stomach. According to the SmPC, interaction studies showed no clinically relevant delay in the absorption of other medicines taken by mouth.

The pen and how to store it

In the HPRA list of authorised medicines, Saxenda has one licence: liraglutide 6 mg/ml solution for injection in a pre-filled pen. Each pen holds 3 ml and can deliver doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg and 3.0 mg; the SmPC lists packs of 1, 3 or 5 pens and notes that not all pack sizes may be marketed. Because the dose is set on the pen, how long one pen lasts depends on the dose you are on.

Before first use, keep the pen in a fridge (2 °C to 8 °C), away from the freezer compartment, and do not freeze it. After first use, it can be kept below 30 °C or in the fridge for up to 1 month. Keep the cap on to protect it from light. The package leaflet expects you to be shown how to use the pen before your first injection, and the instructions for use are printed on the other side of the leaflet.

Dose and how it is increased

Treatment starts at 0.6 mg once a day. The dose is increased by 0.6 mg at intervals of at least one week, to improve how well your stomach tolerates it, until you reach the maintenance dose of 3.0 mg once a day, usually in week 5. Daily doses above 3.0 mg are not recommended. If you do not tolerate the next step for two weeks in a row, the SmPC says stopping treatment should be considered.

WeekDaily dose (SmPC 4.2, package leaflet section 3)
Week 10.6 mg
Week 21.2 mg
Week 31.8 mg
Week 42.4 mg
Week 5 onwards3.0 mg maintenance dose

Injecting and missed doses

Saxenda is injected under the skin of the abdomen, thigh or upper arm, once a day, at any time and with or without food. The package leaflet suggests using it at about the same time each day. Change the injection site every day: the SmPC says this reduces the risk of lumps caused by amyloid deposits under the skin. It must not be injected into a vein or a muscle.

If you remember a missed dose within 12 hours of your usual time, inject it as soon as you remember. If more than 12 hours have passed, skip it and take the next dose the following day at the usual time. Do not use a double dose or increase the next day's dose to make up for the missed one.

How Saxenda differs from the weekly injections

The weight management medicines semaglutide and tirzepatide are injected once a week; liraglutide is injected once a day. The dose steps differ as well: liraglutide reaches its maintenance dose after four weekly increases, while the weekly injections go up every four weeks over a longer period. The substances are different and the doses are not interchangeable, so a change from one product to another is a prescribing decision with its own starting point.

Which schedule suits you, and whether any of these medicines is appropriate at all, depends on your health, your other medicines and how you tolerate treatment. A side-by-side summary of the products is in our comparison of the weight management injections.

Side effects of Saxenda

Gastrointestinal reactions were the most frequently reported side effects in the trials, in 67.9% of adults treated. The SmPC describes most episodes as mild to moderate and transient; they usually occurred during the first weeks of treatment, eased within a few days or weeks and did not lead most people to stop. People aged 65 and over, and people with mild or moderate kidney impairment, may have more stomach side effects.

The package leaflet lists nausea, vomiting, diarrhoea, constipation and headache as very common. Common side effects include indigestion, gastritis, stomach discomfort, upper stomach pain, heartburn, bloating, wind, belching, dry mouth, feeling weak or tired, a changed sense of taste, dizziness, difficulty sleeping (mostly in the first 3 months), gallstones, rash, injection site reactions and low blood sugar. Uncommon side effects include dehydration, a delay in stomach emptying, an inflamed gallbladder and a faster pulse.

  • Severe and persistent pain in the abdomen, which might reach through to your back, with nausea and vomiting can be a sign of pancreatitis: stop Saxenda and contact a doctor immediately.
  • Breathing problems, swelling of the face and throat and a fast heartbeat can be a severe allergic reaction: see a doctor straight away.
  • Passing much less urine, a metallic taste in the mouth or bruising easily can be signs of acute kidney failure, which is rare and mostly followed vomiting, nausea or diarrhoea with fluid loss.
  • A severe form of constipation with stomach ache, bloating and vomiting can be a bowel obstruction.

Warnings and who needs care

The only contraindication in section 4.3 is hypersensitivity to liraglutide or to an ingredient. Section 4.4 says the safety and efficacy of liraglutide for weight management have not been established in people aged 75 or over, people using other weight management products, people whose obesity is caused by a hormonal or eating disorder or by medicines that cause weight gain, and people with severe kidney or liver impairment, and use in these groups is not recommended. It is also not recommended with inflammatory bowel disease or diabetic gastroparesis, or with severe heart failure (NYHA class IV).

Several other points need attention. If pancreatitis is suspected, liraglutide is stopped. Gallstones and gallbladder inflammation were more frequent with liraglutide than with placebo, and only partly because of weight loss. Liraglutide is used with caution if you have thyroid disease. It raises the heart rate, which should be checked at regular intervals, and treatment is stopped if a clinically relevant rise persists. Dehydration from stomach side effects can harm the kidneys.

In diabetes, liraglutide is not a substitute for insulin, and the risk of low blood sugar rises with insulin or a sulphonylurea, whose dose may need to be lowered. Before an operation under general anaesthesia or deep sedation, tell the team you use liraglutide, because food can stay in the stomach longer and cases of stomach contents being inhaled have been reported.

Saxenda and other medicines, including the pill

Interaction studies did not show a clinically relevant delay in the absorption of other oral medicines, and no dose adjustment was needed for paracetamol, atorvastatin, griseofulvin, digoxin or lisinopril. A study with warfarin was not done; when liraglutide is started in someone taking warfarin or a similar anticoagulant, more frequent INR checks are recommended. Severe diarrhoea, which a few people had, may affect the absorption of medicines taken by mouth.

For the contraceptive pill, liraglutide lowered the peak levels of ethinylestradiol and levonorgestrel by 12% and 13% after a single dose, with no clinically relevant effect on overall exposure, and the SmPC expects the contraceptive effect to be unaffected. Saxenda should not be used together with another GLP-1 receptor agonist.

Saxenda and the diabetes product with the same substance

Liraglutide is also the active substance of Victoza, a separate product licensed for adults, adolescents and children aged 10 and over with type 2 diabetes that is not controlled well enough, alongside diet and exercise. Its SmPC sets a maximum of 1.8 mg a day, against 3.0 mg for Saxenda. The two products have different licensed uses and dose schedules, and they are not used together, because Saxenda should not be combined with another GLP-1 receptor agonist.

Pregnancy and breastfeeding

Liraglutide should not be used during pregnancy. Human data are limited, animal studies have shown reproductive toxicity and the potential risk for humans is unknown. If you want to become pregnant, or become pregnant during treatment, liraglutide is stopped. Saxenda should also not be used while breastfeeding, because there is not enough experience: it is not known whether liraglutide passes into human milk.

Is Saxenda available without a prescription?

No. The one Saxenda licence in the HPRA list is prescription only and may not be renewed (category A), with supply through pharmacies only. The HPRA states that it is illegal to sell prescription medicines online in Ireland. Liraglutide offered for sale online without a prescription does not come through the regulated supply route.

A pharmacist in Ireland may dispense a prescription from another EEA country when certain conditions are met, including that the medicine is authorised for use in Ireland and is not a controlled drug. Liraglutide is not named in the schedules of the Misuse of Drugs Regulations 2017.

What does it cost?

We do not quote a price for Saxenda in Ireland, and the medicine is not part of our fee. Our fee covers the doctor's assessment; you pay for the medicine at the pharmacy, at the pharmacy's price. The fee for the assessment is shown on the button on this page. Because one pen delivers several doses, how often you need a new pen depends on the dose you are on, and that changes during the first weeks.

We make no claim about whether a medicine dispensed on this prescription counts towards a medical card or the Drugs Payment Scheme. How the costs of weight management treatment are made up is explained in our article on what weight loss injections cost.

Requesting a prescription

Requests for weight management medicines go through Weight Loss Treatment, both for starting treatment and for continuing treatment another prescriber began. You fill in a medical questionnaire, naming the medicine or describing your situation and answering questions about your health, your other medicines and your conditions. There is no video call and no telephone consultation. If the doctor has questions, they ask them in writing in the chat in your account, and you get an email to let you know. The doctor may ask for records, test results or a reading such as your blood pressure, may advise you to be seen in person, and may decline.

If the doctor issues a prescription, you receive it as a PDF by email. You print the PDF and take the printout to a pharmacy. A pharmacist in Ireland decides whether to dispense a prescription written by a doctor in another EEA country and may decline. This is not an Irish ePrescription and it is not sent through Healthmail.

Package leaflet and medical review

The package leaflet in your pack is the reference for the pen you use, including the instructions for use and storage. The European Medicines Agency publishes the full product information, because Saxenda is authorised centrally for the European Union. Use of liraglutide is supervised by a doctor; this page is general information and does not replace advice about your own treatment.

Medically reviewed by Damian Wojno, a doctor registered in Poland (licence no. 3211301, Regional Medical Chamber in Olsztyn). He is not on the register of the Irish Medical Council.

Do I need a prescription for Saxenda in Ireland?

Yes. The Saxenda licence in the HPRA list is prescription only and may not be renewed (category A), and it is supplied through pharmacies only. A doctor has to assess whether it is suitable for you before it can be prescribed.

How is the Saxenda dose increased?

You start with 0.6 mg once a day and increase by 0.6 mg each week, so the usual steps are 1.2 mg in week 2, 1.8 mg in week 3 and 2.4 mg in week 4, reaching 3.0 mg from week 5. The interval between steps is at least one week, and doses above 3.0 mg a day are not recommended.

When is Saxenda stopped?

For adults, the SmPC says treatment should be stopped after 12 weeks on 3.0 mg a day if you have not lost at least 5% of your initial body weight. Stopping should also be considered if you cannot tolerate a dose step for two weeks in a row, and liraglutide is stopped if pancreatitis is suspected or if you become pregnant.

What if I miss a dose of Saxenda?

If you remember within 12 hours of your usual time, inject it as soon as you remember. If more than 12 hours have passed, skip it and inject the next dose the following day at the usual time. Do not take a double dose or increase the next dose to make up for it.

What are the most common side effects of Saxenda?

Nausea, vomiting, diarrhoea, constipation and headache are very common, and usually go away after a few days or weeks. Indigestion, heartburn, bloating, dry mouth, tiredness, dizziness, difficulty sleeping, gallstones and injection site reactions are common. Severe, persistent abdominal pain reaching through to the back needs a doctor immediately.

Is Saxenda the same as Victoza?

Both contain liraglutide, but they are separate products. Saxenda is licensed for weight management, up to 3.0 mg a day; Victoza is licensed for type 2 diabetes, up to 1.8 mg a day. They are not interchangeable and are not used together.